STK33 Antikörper (AA 231-514)
Kurzübersicht für STK33 Antikörper (AA 231-514) (ABIN7168993)
Target
Alle STK33 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 231-514
- 
                                            Kreuzreaktivität
- Human, Maus
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human Serine/threonine-protein kinase 33 protein (231-514AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200,
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - STK33 (serine/threonine Kinase 33 (STK33))
- 
                                            Andere Bezeichnung
- STK33
- 
                                            Hintergrund
- 
                        Background: Serine/threonine protein kinase which phosphorylates VIME. May play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME (By similarity). Not essential for the survival of KRAS-dependent AML cell lines. Aliases: Hypothetical protein FLJ35932 antibody, Serine threonine kinase 33 antibody, Serine/threonine kinase 33 antibody, Serine/threonine protein kinase 33 antibody, Serine/threonine-protein kinase 33 antibody, STK 33 antibody, Stk33 antibody, STK33_HUMAN antibody 
- 
                                            UniProt
- Q9BYT3
 Target
- 
                    
 
                                     
                                     
                                    